beta-alanine has been researched along with Seizures in 10 studies
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "beta-Alanine is a central-nervous-system depressant." | 5.24 | Hyper-beta-alaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures. ( Davies, E; Pueschel, S; Scriver, CR, 1966) |
| "Taurine treatment limited mitochondrial superoxide generation, supporting a role for taurine in maintaining complex I activity." | 1.43 | Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia. ( Alexeyev, M; Jong, CJ; Mehdi, AB; Schaffer, SW; Shetewy, A; Shimada-Takaura, K; Takahashi, K; Warner, D, 2016) |
| " Neurotoxic signs such as hyperesthesia and/or excitement, as well as convulsions, were observed in both FBAL x HCl and FA x Na groups; these toxic signs were also found in the UFT group." | 1.32 | Neurotoxic effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs. ( Ariyoshi, T; Yada, H; Yamashita, K, 2004) |
| "Convulsant activity of pazufloxacin mesilate (PZFX mesilate), a new quinolone antibacterial agent for intravenous use, in combination with nonsteroidal anti-inflammatory drug (NSAID) was investigated in mice after intravenous or intracerebroventricular administration." | 1.31 | [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration]. ( Fukuda, H; Kawamura, Y, 2002) |
| "Diazepam, known to produce its anticonvulsant, sedative and muscle relaxant effects through its interaction either with central GABA or glycine receptors was found to be the most potent (48." | 1.27 | Effects of glycine and other inhibitory amino acid neurotransmitters on strychnine convulsive threshold in mice. ( Sangiah, S, 1985) |
| "Homotaurine is a powerful GABA agonist that exerts a central action upon parenteral administration." | 1.26 | Activating effects of homotaurine and taurine on corticoreticular epilepsy. ( Black, JA; Fariello, RG; Golden, GT, 1981) |
| "beta-Alanine is a central-nervous-system depressant." | 1.24 | Hyper-beta-alaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures. ( Davies, E; Pueschel, S; Scriver, CR, 1966) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakada, K | 1 |
| Yoshikawa, M | 1 |
| Ide, S | 1 |
| Suemasa, A | 1 |
| Kawamura, S | 1 |
| Kobayashi, T | 1 |
| Masuda, E | 1 |
| Ito, Y | 1 |
| Hayakawa, W | 1 |
| Katayama, T | 1 |
| Yamada, S | 1 |
| Arisawa, M | 1 |
| Minami, M | 1 |
| Shuto, S | 1 |
| Shetewy, A | 1 |
| Shimada-Takaura, K | 1 |
| Warner, D | 1 |
| Jong, CJ | 1 |
| Mehdi, AB | 1 |
| Alexeyev, M | 1 |
| Takahashi, K | 1 |
| Schaffer, SW | 1 |
| Fukuda, H | 1 |
| Kawamura, Y | 1 |
| Yamashita, K | 1 |
| Yada, H | 1 |
| Ariyoshi, T | 1 |
| Scriver, CR | 1 |
| Pueschel, S | 1 |
| Davies, E | 1 |
| Fariello, RG | 1 |
| Golden, GT | 1 |
| Black, JA | 1 |
| Katsuki, K | 1 |
| Shinohara, K | 1 |
| Yamada, T | 1 |
| Marson, CA | 1 |
| Hammond, EJ | 1 |
| Wilder, BJ | 1 |
| Sangiah, S | 1 |
1 review available for beta-alanine and Seizures
| Article | Year |
|---|---|
Gamma-vinyl GABA.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Aminocaproates; Animals; Behavior, Animal; beta-Alanine; | 1985 |
9 other studies available for beta-alanine and Seizures
| Article | Year |
|---|---|
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
Topics: Animals; Anticonvulsants; Brain; Cyclopropanes; GABA Modulators; GABA Plasma Membrane Transport Prot | 2013 |
Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia.
Topics: Animals; beta-Alanine; Disorders of Excessive Somnolence; Electron Transport Complex I; Embryo, Mamm | 2016 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agent | 2002 |
Neurotoxic effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs.
Topics: Administration, Oral; Animals; beta-Alanine; Dogs; Fluoroacetates; Fluorouracil; Hyperesthesia; Male | 2004 |
Hyper-beta-alaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures.
Topics: 4-Aminobutyrate Transaminase; Amino Acid Metabolism, Inborn Errors; beta-Alanine; Disorders of Exces | 1966 |
Activating effects of homotaurine and taurine on corticoreticular epilepsy.
Topics: Animals; beta-Alanine; Cats; Electrodes, Implanted; Electroencephalography; gamma-Aminobutyric Acid; | 1981 |
A case of fatal seizure and unconsciousness caused by panipenem/betamipron.
Topics: Aged; Aged, 80 and over; beta-Alanine; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Sei | 1998 |
An experimental model to investigate disinhibitory mechanisms in penicillin epileptogenesis.
Topics: Animals; beta-Alanine; Cats; gamma-Aminobutyric Acid; Glycine; Homocysteine; Iontophoresis; Neurotra | 1978 |
Effects of glycine and other inhibitory amino acid neurotransmitters on strychnine convulsive threshold in mice.
Topics: Alanine; Animals; beta-Alanine; Diazepam; Dose-Response Relationship, Drug; Glycine; Male; Mice; Mic | 1985 |